28 May 2014 - Deborah Wilkes
Archived
A lot changed in the global OTC industry in the space of 15 days. Two deals announced by GlaxoSmithKline and Bayer will lift them above Johnson & Johnson in the rankings, giving the global OTC industry a new top two. Furthermore, these deals highlighted the appeal of asset swaps to pharmaceutical companies seeking to reshape their businesses.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.